Natixis Advisors, L.P. Icu Medical Inc Transaction History

Natixis Advisors, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$161.03 - $209.15 $65,539 - $85,124	407 Added 2.14%	19,469 $3.47 Million
Q1 2023 May 11, 2023	BUY	$153.15 - $198.21 $1.13 Million - $1.47 Million	7,403 Added 63.5%	19,062 $3.14 Million
Q4 2022 Jan 27, 2023	BUY	$136.25 - $165.56 $130,800 - $158,937	960 Added 8.97%	11,659 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$149.44 - $188.1 $1.6 Million - $2.01 Million	10,699 New	10,699 $1.61 Million

312

23.6M

67.6K

37.1K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $3.58B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.